Abstract
OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 199-200 |
| Number of pages | 2 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 14 |
| Issue number | 2 |
| State | Published - Feb 1 2015 |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain. / Ho, Derek; Jagdeo, Jared.
In: Journal of Drugs in Dermatology, Vol. 14, No. 2, 01.02.2015, p. 199-200.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain
AU - Ho, Derek
AU - Jagdeo, Jared
PY - 2015/2/1
Y1 - 2015/2/1
N2 - OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.
AB - OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.
UR - http://www.scopus.com/inward/record.url?scp=84922466580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922466580&partnerID=8YFLogxK
M3 - Article
C2 - 25689816
AN - SCOPUS:84922466580
VL - 14
SP - 199
EP - 200
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
SN - 1545-9616
IS - 2
ER -